Catalyst Wire Dossier Catalyst Wire Dossier

Balicatib

balicatib · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Balicatib, covering 2017-03-28 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Efficacy of Balicatib (AAE581) in Adults With Osteoarthritis of the Knee [Phase 2]

See pricing